Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04:47 | G Sachs Adds CSPC PHARMA TP to $10.26 | 2 | AASTOCKS | ||
04:47 | UBS Hikes CSPC PHARMA TP to $10.1; 1Q Results Beat | 2 | AASTOCKS | ||
04:47 | Daiwa Adds TP of CSPC PHARMA to $8; 1Q24 Results Beat | 2 | AASTOCKS | ||
04:47 | Nomura Lifts CSPC PHARMA TP to $10.07; Strong Growth Guidance Intact | 2 | AASTOCKS | ||
04:17 | BOCI Lifts CSPC PHARMA TP to $10.2 on Strong Finished Drug Sales, 1Q Results Beat | 2 | AASTOCKS | ||
Mo | CSPC PHARMA Surges 4%+ as 1Q NP Up 13% | 5 | AASTOCKS | ||
Mo | CSPC PHARMA 1Q Net Profit RMB1.613B, Up 12.9% | 7 | AASTOCKS | ||
Mo | CSPC PHARMA (01093): QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2024 | 7 | HKEx | ||
21.05. | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - AMENDMENTS TO THE RULES OF THE RESTRICTED SHARE AWARD SCHEME | 2 | HKEx | ||
17.05. | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - RECOMBINANT FULLY HUMAN ANTI-BETA KLOTHO MONOCLONAL ANTIBODY DRUG (JMT202) OBTAINS CLINICAL TRIAL APPROVAL | 2 | HKEx | ||
14.05. | CSPC PHARMA (01093): DATE OF BOARD MEETING | 3 | HKEx | ||
14.05. | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PERAMIVIR INJECTION OBTAINS DRUG REGISTRATION APPROVAL | 1 | HKEx | ||
03.05. | CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURN | 3 | HKEx | ||
26.04. | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. | 3 | HKEx | ||
25.04. | CSPC PHARMA (01093): NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM | 2 | HKEx | ||
25.04. | CSPC PHARMA (01093): NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM | 2 | HKEx | ||
25.04. | CSPC PHARMA (01093): LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM | 1 | HKEx | ||
25.04. | CSPC PHARMA (01093): PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF) | 1 | HKEx | ||
25.04. | CSPC PHARMA (01093): NOTICE OF ANNUAL GENERAL MEETING | 2 | HKEx | ||
25.04. | CSPC PHARMA (01093): PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, MANDATE TO GRANT OPTIONS AND RE-ELECTION OF RETIRING DIRECTORS ... | 4 | HKEx |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NEL | 3.504 |
GAMESTOP | 3.187 |
NVIDIA | 2.795 |
EVOTEC | 2.534 |
TUI | 1.592 |
BAYER | 1.341 |
BIONTECH | 1.027 |
PLUG POWER | 952 |
RHEINMETALL | 854 |
VOLKSWAGEN | 770 |
DEUTSCHE LUFTHANSA | 732 |
SUPER MICRO COMPUTER | 711 |
SIEMENS ENERGY | 672 |
BYD | 658 |
MERCEDES-BENZ | 631 |
COMMERZBANK | 555 |
AIXTRON SE | 546 |
RWE | 543 |
HEIDELBERGER DRUCK | 540 |
TESLA | 514 |
DEUTSCHE BANK | 512 |
RENK GROUP | 499 |
AMC ENTERTAINMENT | 492 |
BASF | 469 |
NORDEX | 469 |